Advisory Services Network’s Acumen Pharmaceuticals ABOS Stock Holding History

Advisory Services Network’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,111	Closed	-$2.62K	–	2173
2026 Q1	$2.62K	Buy	+1,111	New	+$2.83K	﹤0.01%	4069
2025 Q4	–	Sell	-1,111	Closed	-$1.9K	–	1809
2025 Q3	$1.9K	Buy	+1,111	New	+$1.54K	﹤0.01%	3810
2024 Q1	–	Sell	-1,000	Closed	-$3.84K	–	1459
2023 Q4	$3.84K	Buy	+1,000	New	+$2.97K	﹤0.01%	3199

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Advisory Services Network's ABOS Position: Q2 2026 in Review

Advisory Services Network sold out of Acumen Pharmaceuticals (ABOS) in Q2 2026, closing a stake of 1,111 shares — an estimated $2.62K sold.

Advisory Services Network first reported a position in ABOS in Q4 2023 and held it in 3 quarters. The position peaked at $3.84K in Q4 2023. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

Advisory Services Network reported no remaining Acumen Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 1,111 Acumen Pharmaceuticals shares in Q2 2026, an estimated $2.62K.
Advisory Services Network first reported a position in Acumen Pharmaceuticals in Q4 2023 and held it in 3 quarters.
Advisory Services Network's Acumen Pharmaceuticals position peaked at $3.84K in Q4 2023.
96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.